Chronix Biomedical
San Jose
About Chronix Biomedical
Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary technology that measures and categorizes circulating nucleic acids, DNA sequences circulating in the blood that are associated with specific changes in disease and health status. Chronix plans to collaborate with a variety of partners to develop and market its DNA-based assays that have the potential to transform the management of a broad range of cancers and other conditions. Chronix is headquartered in San Jose, California and has research facilities in Germany.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $21.5M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2017)
- Website: chronixbiomedical.com
- Phone: 408-960-2306
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/chronix-biomedical-76051 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.